Fever News and Research

RSS

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved NOXAFIL® (posaconazole) 100 mg delayed-release tablets.

27 Nov 2013

Researchers find that hay fever and allergies make migraines worse

People with migraine who also battle allergies and hay fever (rhinitis) endure a more severe form of headaches than their peers who struggle with migraine, but aren't affected by the seasonal or year-round sniffles, according to researchers from the University of Cincinnati, Montefiore Medical Center and the Albert Einstein College of Medicine of Yeshiva University and Vedanta Research.

26 Nov 2013

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

25 Nov 2013

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced the publication of a scientific paper by Dr. John R. Crew of Seton Medical Center, Daly City, California, describing the first use of adjunctive NeutroPhase irrigation therapy in conjunction with Negative Pressure Wound Therapy to successfully manage the severely-infected wound in the arm of a patient with life-threatening 'flesh-eating' disease.

20 Nov 2013

Higher 36°C temperature as effective as 33°C for therapeutic hypothermia treatment

Therapeutic hypothermia - cooling the body and brain down to 33-C - is the method used worldwide to treat cardiac arrest, even though a lower body temperature may raise the risk of side-effects. However, keeping the temperature steady at 36-C is just as effective, a study led by Lund University researchers has found.

20 Nov 2013

Segregating household sleeping arrangements can help prevent malaria spread

Better malaria control might come from segregating household sleeping arrangements, according to a new study co-authored by a University of Guelph professor.

19 Nov 2013

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational intravenous solution formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for priority review by the U.S. Food and Drug Administration.

18 Nov 2013

Genetic mutations in parasite cause over 100 million cases of malaria annually in Africa

Researchers at Case Western Reserve University and Cleveland Clinic Lerner Research Institute have discovered recent genetic mutations in a parasite that causes over 100 million cases of malaria annually-changes that may render tens of millions of Africans who had been considered resistant, susceptible to infection.

16 Nov 2013

Taiwan scientists confirm world’s first case of wild avian influenza A H6N1 virus in human

Scientists from Taiwan report on the world’s first confirmed case of human infection with a wild avian influenza A H6N1 virus in The Lancet Respiratory Medicine.

14 Nov 2013

Research findings could help decrease risk of dengue

A study by an international team of researchers led by Anna M. Stewart Ibarra, Ph.D., of the Center for Global Health and Translational Science at SUNY Upstate Medical University, has provided public health officials with information that will help decrease the risk of dengue, a life-threatening mosquito-borne viral disease that is now one of the fastest spreading tropical diseases globally.

14 Nov 2013

New biomedical instrument anticipated to help breakthroughs in animal, human health

A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.

13 Nov 2013

New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients

New data presented at the 6th Pan Asian Committee for Treatment and Research in Multiple Sclerosis, show positive preliminary results from PERSIST, a 12-month, Phase 4 clinical study of once weekly Avonex Pen for patients with relapsing-remitting multiple sclerosis.

13 Nov 2013

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant.

12 Nov 2013

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.

11 Nov 2013

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

Walter Quan, Jr., MD Chief of Medical Oncology and Director of Immunotherapy at Cancer Treatment Centers of America- Western Regional Medical Center is presenting new findings that are showing a major benefit to cancer patients.

11 Nov 2013

New 'clinical score' test for patients with sore throats reduces antibiotics usage nearly 30%

A new 'clinical score' test for patients with sore throats could reduce the amount of antibiotics prescribed and result in patients feeling better more quickly, research in the British Medical Journal shows.

11 Nov 2013

Study: Hay fever more prevalent in children living in southeastern and southern states

If you think your child's stuffy nose is due to an autumn cold, you might want to consider allergies, especially if you live in the southern region of the United States. A study being presented this week at the Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) found hay fever is more prevalent in children living in the southeastern and southern states.

8 Nov 2013

Oral allergy syndrome sufferers with hypertension may be at increased risk for severe reaction

Oral allergy syndrome sufferers that take high blood pressure medications may experience extreme facial swelling and difficulty breathing the next time they bite into a juicy apple.

8 Nov 2013

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced third quarter 2013 financial results.

5 Nov 2013

Probiotics may help keep bad germs at bay

Microbes are everywhere - thousands of species are in your mouth, and thousands are in a glass of tap water. The ones in your mouth are mostly harmless - as long as you brush and floss so they don't form a biofilm that allows gum disease a path into the blood stream.

4 Nov 2013

Fever News and Research

Merck announces approval of NOXAFIL delayed-release tablets by FDA

Researchers find that hay fever and allergies make migraines worse

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

Higher 36°C temperature as effective as 33°C for therapeutic hypothermia treatment

Segregating household sleeping arrangements can help prevent malaria spread

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

Genetic mutations in parasite cause over 100 million cases of malaria annually in Africa

Taiwan scientists confirm world’s first case of wild avian influenza A H6N1 virus in human

Research findings could help decrease risk of dengue

New biomedical instrument anticipated to help breakthroughs in animal, human health

New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

CTCA doctor presents cutting-edge treatments for cancer patients to medical colleagues

New 'clinical score' test for patients with sore throats reduces antibiotics usage nearly 30%

Study: Hay fever more prevalent in children living in southeastern and southern states

Oral allergy syndrome sufferers with hypertension may be at increased risk for severe reaction

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Probiotics may help keep bad germs at bay

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News